Filho Jose Octavio Pinto Costa 4
4 · Monopar Therapeutics · Filed Jul 13, 2021
Insider Transaction Report
Form 4
Filho Jose Octavio Pinto Costa
Chief Medical Officer
Transactions
- Award
Stock Options
2021-07-12+91,500→ 91,500 totalExercise: $5.59Exp: 2031-07-11→ Common Stock (91,500 underlying)
Footnotes (1)
- [F1]Options vest 6/48ths on January 12, 2022 and 1/48th per month thereafter.